XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Cash and cash equivalents    
Noninterest-bearing $ 542 $ 502
Interest-bearing 5,029 4,560
Total cash and cash equivalents 5,571 5,062
Carrying amount, equity investments without a readily determinable fair value 681 1,102
Available-for-sale securities [1] 29,541 33,587
Held-to-maturity securities 1,062 1,170
Loans held-for-sale, net 654 549
Finance receivables and loans, net    
Finance receivables and loans, net of unearned income 135,748 122,268
Allowance for loan losses (3,711) (3,267)
Total finance receivables and loans, net 132,037 119,001
Investment in operating leases, net 10,444 10,862
Premiums receivable and other insurance assets 2,698 2,724
Other assets 9,138 8,057
Total assets 191,826 182,114
Deposit liabilities    
Noninterest-bearing 185 150
Interest-bearing 152,112 141,408
Total deposit liabilities 152,297 141,558
Short-term borrowings 2,399 0
Long-term debt 17,762 17,029
Interest payable 408 210
Unearned insurance premiums and service revenue 3,453 3,514
Accrued expenses and other liabilities 2,648 2,753
Total liabilities 178,967 165,064
Commitments and contingencies (refer to Note 28 and Note 29)
Equity    
Common stock and paid-in capital ($0.01 par value, shares authorized 1,100,000,000; issued 507,682,838 and 504,521,535; and outstanding 299,324,357 and 337,940,636) 21,816 21,671
Preferred stock 2,324 2,324
Accumulated deficit (384) (1,599)
Accumulated other comprehensive loss (4,059) (158)
Treasury stock, at cost (208,358,481 and 166,580,899 shares) (6,838) (5,188)
Total equity 12,859 17,050
Total liabilities and equity $ 191,826 $ 182,114
[1] Refer to Note 8 for discussion of investment securities pledged as collateral.